EXPERIMENTAL STUDIES ON THE ACTION OF STREPTOMYCIN, AUREOMYCIN, AND CHLOROMYCETIN ON BRUCELLA

^{Division of Internal Medicine, University of Minnesota Medical School, Minneapolis}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

This investigation was supported (in part) by a research grant from the Division of Research Grants and Fellowships of the National Institutes of Health, United States Public Health Service, and by a grant from the Lederle Laboratories. The aureomycin was supplied by the Lederle Laboratories; the dihydrostreptomycin, by E. R. Squibb Company; polymyxin, by the Stamford Research Laboratories, American Cyanamid Company; bacitracin and Q-19, by the Upjohn Company; and chloromycetin, by Parke, Davis and Company.

Find articles by Yow, E. in: PubMed | Google Scholar

^{Division of Internal Medicine, University of Minnesota Medical School, Minneapolis}

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

This investigation was supported (in part) by a research grant from the Division of Research Grants and Fellowships of the National Institutes of Health, United States Public Health Service, and by a grant from the Lederle Laboratories. The aureomycin was supplied by the Lederle Laboratories; the dihydrostreptomycin, by E. R. Squibb Company; polymyxin, by the Stamford Research Laboratories, American Cyanamid Company; bacitracin and Q-19, by the Upjohn Company; and chloromycetin, by Parke, Davis and Company.

Find articles by Spink, W. in: PubMed | Google Scholar